Top compounds associated with response to PLBD2


Feature Type Standardized
Nominal ANOVA
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.22 9e-12
mRNA ciclopirox CTRPv2 pan-cancer AAC -0.24 5e-11
mRNA pac-1 CTRPv2 pan-cancer AAC -0.22 4e-08
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.18 5e-08
mRNA manumycin A CTRPv2 pan-cancer AAC -0.2 9e-08
mRNA Topotecan CTRPv2 pan-cancer AAC -0.2 9e-08
mRNA PX-12 CTRPv2 pan-cancer AAC -0.17 2e-07
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA clofarabine CTRPv2 pan-cancer AAC -0.17 3e-07
mRNA 3-Cl-AHPC CTRPv2 pan-cancer AAC -0.2 4e-07
Download CSV